Epigenetic Regulation of TP53 Is Involved in Prostate Cancer Radioresistance and DNA Damage Response Signaling

Scientists generated a radioresistant prostate cancer (PCa) cell line, and found p53 to be highly expressed in radioresistant PCa cells, as well as in PCa patients with recurrent/disease progression submitted to radiotherapy.